{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:56:28Z","timestamp":1776462988410,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Key Research and Development Projects of Anhui Province","award":["1804h08020228"],"award-info":[{"award-number":["1804h08020228"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10787-025-01735-9","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T12:20:11Z","timestamp":1744892411000},"page":"2769-2778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The presumable combined effects of hydroxychloroquine and its metabolites on the blood lipids and glucose in the treatment of rheumatoid arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"Huaixuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-6509","authenticated-orcid":false,"given":"Zongwen","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"9","key":"1735_CR1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588. https:\/\/doi.org\/10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1735_CR2","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1016\/j.jacl.2024.04.001","volume":"18","author":"HE Bays","year":"2024","unstructured":"Bays HE, Kirkpatrick CF, Maki KC, Toth PP, Morgan RT, Tondt J, Christensen SM, Dixon DL, Jacobson TA (2024) Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. J Clin Lipidol 18(3):e320\u2013e350. https:\/\/doi.org\/10.1016\/j.jacl.2024.04.001","journal-title":"J Clin Lipidol"},{"issue":"2","key":"1735_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","volume":"42","author":"I Ben-Zvi","year":"2012","unstructured":"Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y (2012) Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol 42(2):145\u2013153. https:\/\/doi.org\/10.1007\/s12016-010-8243-x","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"1735_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/rheumatology\/kem378","volume":"47","author":"DU Cansu","year":"2008","unstructured":"Cansu DU, Korkmaz C (2008) Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA. Rheumatology (Oxford) 47(3):378\u2013379. https:\/\/doi.org\/10.1093\/rheumatology\/kem378","journal-title":"Rheumatology (Oxford)"},{"issue":"18","key":"1735_CR5","doi-asserted-by":"publisher","first-page":"9925","DOI":"10.3390\/ijms25189925","volume":"25","author":"A Caraba","year":"2024","unstructured":"Caraba A, Stancu O, Cri\u0219an V, Georgescu D (2024) Anti TNF-alpha treatment improves microvascular endothelial dysfunction in rheumatoid arthritis patients. Int J Mol Sci 25(18):9925. https:\/\/doi.org\/10.3390\/ijms25189925","journal-title":"Int J Mol Sci"},{"key":"1735_CR6","doi-asserted-by":"publisher","first-page":"1353334","DOI":"10.3389\/fendo.2024.1353334","volume":"15","author":"B Chen","year":"2024","unstructured":"Chen B, Chen Y, Wang Y, Xin Q, Ma D (2024) The association between rapid growth and lipid profile: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 15:1353334. https:\/\/doi.org\/10.3389\/fendo.2024.1353334","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1735_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3803\/EnM.2024.1951","volume":"39","author":"JH Cho","year":"2024","unstructured":"Cho JH, Suh S (2024) Glucocorticoid-induced hyperglycemia: a neglected problem. Endocrinol Metab (Seoul) 39(2):222\u2013238. https:\/\/doi.org\/10.3803\/EnM.2024.1951","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"12","key":"1735_CR8","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID del Rinc\u00f3n","year":"2001","unstructured":"del Rinc\u00f3n ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44(12):2737\u20132745 (10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-%23)","journal-title":"Arthritis Rheum"},{"key":"1735_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/OARRR.S264466","volume":"12","author":"G Dessie","year":"2020","unstructured":"Dessie G, Tadesse Y, Demelash B, Genet S (2020) Assessment of serum lipid profiles and high-sensitivity C-reactive protein among patients suffering from rheumatoid arthritis at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: a cross-sectional study. Open Access Rheumatol 12:223\u2013232. https:\/\/doi.org\/10.2147\/OARRR.S264466","journal-title":"Open Access Rheumatol"},{"issue":"3","key":"1735_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/imj.15908","volume":"53","author":"JL Fairley","year":"2023","unstructured":"Fairley JL, Nikpour M, Mack HG, Brosnan M, Saracino AM, Pellegrini M, Wicks IP (2023) How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice. Intern Med J 53(3):311\u2013317. https:\/\/doi.org\/10.1111\/imj.15908","journal-title":"Intern Med J"},{"issue":"4","key":"1735_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00393-021-00973-w","volume":"80","author":"C Fiehn","year":"2021","unstructured":"Fiehn C (2021) Glucocorticoid-free and low-dose glucocorticoid treatment of rheumatoid arthritis. Z Rheumatol 80(4):305\u2013313. https:\/\/doi.org\/10.1007\/s00393-021-00973-w","journal-title":"Z Rheumatol"},{"issue":"4","key":"1735_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev 20(4):102776. https:\/\/doi.org\/10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun Rev"},{"issue":"7","key":"1735_CR13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Mill\u00e1n I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA (2021) 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 73(7):924\u2013939. https:\/\/doi.org\/10.1002\/acr.24596","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"1735_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/1570161117666190619143842","volume":"18","author":"GE Fragoulis","year":"2020","unstructured":"Fragoulis GE, Panayotidis I, Nikiphorou E (2020) Cardiovascular risk in rheumatoid arthritis and mechanistic links: from pathophysiology to treatment. Curr Vasc Pharmacol 18(5):431\u2013446. https:\/\/doi.org\/10.2174\/1570161117666190619143842","journal-title":"Curr Vasc Pharmacol"},{"issue":"4","key":"1735_CR15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/10409238.2021.1925217","volume":"56","author":"AG Groenen","year":"2021","unstructured":"Groenen AG, Halmos B, Tall AR, Westerterp M (2021) Cholesterol efflux pathways, inflammation, and atherosclerosis. Crit Rev Biochem Mol Biol 56(4):426\u2013439. https:\/\/doi.org\/10.1080\/10409238.2021.1925217","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"2","key":"1735_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5152\/eurjrheum.2020.20193","volume":"8","author":"M Guevara","year":"2021","unstructured":"Guevara M, Ng B (2021) Positive effect of hydroxychloroquine on lipid profiles of patients with rheumatoid arthritis: a veterans affair cohort. Eur J Rheumatol 8(2):62\u201366. https:\/\/doi.org\/10.5152\/eurjrheum.2020.20193","journal-title":"Eur J Rheumatol"},{"issue":"5","key":"1735_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103539","volume":"23","author":"Y Hajiesmaeili","year":"2024","unstructured":"Hajiesmaeili Y, Tamhankar P, Stranges S, Barra L (2024) Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: a scoping review. Autoimmun Rev 23(5):103539. https:\/\/doi.org\/10.1016\/j.autrev.2024.103539","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1735_CR18","first-page":"661","volume":"20","author":"HN Hodis","year":"1993","unstructured":"Hodis HN, Quismorio FP Jr, Wickham E, Blankenhorn DH (1993) The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus. J Rheumatol 20(4):661\u2013665","journal-title":"J Rheumatol"},{"issue":"11","key":"1735_CR19","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1136\/ard.2011.151464","volume":"70","author":"JN Hoes","year":"2011","unstructured":"Hoes JN, van der Goes MC, van Raalte DH, van der Zijl NJ, den Uyl D, Lems WF, Lafeber FP, Jacobs JW, Welsing PM, Diamant M, Bijlsma JW (2011) Glucose tolerance, insulin sensitivity and beta-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids. Ann Rheum Dis 70(11):1887\u20131894. https:\/\/doi.org\/10.1136\/ard.2011.151464","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1735_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jama.2018.9122","volume":"320","author":"J Jin","year":"2018","unstructured":"Jin J (2018) Risk assessment for cardiovascular disease with nontraditional risk factors. JAMA 320(3):316. https:\/\/doi.org\/10.1001\/jama.2018.9122","journal-title":"JAMA"},{"issue":"4","key":"1735_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/acr.24850","volume":"75","author":"A Jorge","year":"2023","unstructured":"Jorge A, Lu N, Choi H, Esdaile JM, Lacaille D, Avina-Zubieta JA (2023) Hydroxychloroquine use and cardiovascular events among patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 75(4):743\u2013748. https:\/\/doi.org\/10.1002\/acr.24850","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"1735_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164564","volume":"11","author":"JY Kim","year":"2016","unstructured":"Kim JY, Lee EY, Park JK, Song YW, Kim JR, Cho KH (2016) Patients with rheumatoid arthritis show altered lipoprotein profiles with dysfunctional high-density lipoproteins that can exacerbate inflammatory and atherogenic process. PLoS ONE 11(10):e0164564. https:\/\/doi.org\/10.1371\/journal.pone.0164564","journal-title":"PLoS ONE"},{"key":"1735_CR23","doi-asserted-by":"publisher","first-page":"1190607","DOI":"10.3389\/fimmu.2023.1190607","volume":"14","author":"Q Lei","year":"2023","unstructured":"Lei Q, Yang J, Li L, Zhao N, Lu C, Lu A, He X (2023) Lipid metabolism and rheumatoid arthritis. Front Immunol 14:1190607. https:\/\/doi.org\/10.3389\/fimmu.2023.1190607","journal-title":"Front Immunol"},{"issue":"2","key":"1735_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/art.20853","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52(2):402\u2013411. https:\/\/doi.org\/10.1002\/art.20853","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1735_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13075-022-02822-w","volume":"24","author":"C Mart\u00edn-Gonz\u00e1lez","year":"2022","unstructured":"Mart\u00edn-Gonz\u00e1lez C, Mart\u00edn-Folgueras T, Quevedo-Abeledo JC, de Vera-Gonz\u00e1lez A, Gonz\u00e1lez-Delgado A, de Armas-Rillo L, Gonz\u00e1lez-Gay M\u00c1, Ferraz-Amaro I (2022) Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis. Arthritis Res Ther 24(1):126. https:\/\/doi.org\/10.1186\/s13075-022-02822-w","journal-title":"Arthritis Res Ther"},{"issue":"16","key":"1735_CR26","doi-asserted-by":"publisher","first-page":"8503","DOI":"10.3390\/ijms22168503","volume":"22","author":"N Mir","year":"2021","unstructured":"Mir N, Chin SA, Riddell MC, Beaudry JL (2021) Genomic and non-genomic actions of glucocorticoids on adipose tissue lipid metabolism. Int J Mol Sci 22(16):8503. https:\/\/doi.org\/10.3390\/ijms22168503","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1735_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jbspin.2016.09.001","volume":"84","author":"J Nicolau","year":"2017","unstructured":"Nicolau J, Lequerr\u00e9 T, Bacquet H, Vittecoq O (2017) Rheumatoid arthritis, insulin resistance, and diabetes. Jt Bone Spine 84(4):411\u2013416. https:\/\/doi.org\/10.1016\/j.jbspin.2016.09.001","journal-title":"Jt Bone Spine"},{"key":"1735_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111269","volume":"126","author":"M Pan","year":"2024","unstructured":"Pan M, Jin R, Dai Y, Gao B, Liu Y, Peng X, Qiao J, Shuai Z (2024) The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus. Int Immunopharmacol 126:111269. https:\/\/doi.org\/10.1016\/j.intimp.2023.111269","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1735_CR29","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3899\/jrheum.090994","volume":"37","author":"SK Penn","year":"2010","unstructured":"Penn SK, Kao AH, Schott LL, Elliott JR, Toledo FG, Kuller L, Manzi S, Wasko MC (2010) Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 37(6):1136\u20131142. https:\/\/doi.org\/10.3899\/jrheum.090994","journal-title":"J Rheumatol"},{"key":"1735_CR30","doi-asserted-by":"publisher","first-page":"9670434","DOI":"10.1155\/2017\/9670434","volume":"2017","author":"H Pi","year":"2017","unstructured":"Pi H, Zhou H, Jin H, Ning Y, Wang Y (2017) Abnormal glucose metabolism in rheumatoid arthritis. Biomed Res Int 2017:9670434. https:\/\/doi.org\/10.1155\/2017\/9670434","journal-title":"Biomed Res Int"},{"issue":"12","key":"1735_CR31","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3899\/jrheum.150166","volume":"42","author":"FA Pinheiro","year":"2015","unstructured":"Pinheiro FA, Souza DC, Sato EI (2015) A study of multiple causes of death in rheumatoid arthritis. J Rheumatol 42(12):2221\u20132228. https:\/\/doi.org\/10.3899\/jrheum.150166","journal-title":"J Rheumatol"},{"issue":"1","key":"1735_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","volume":"77","author":"C Rempenault","year":"2018","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C (2018) Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 77(1):98\u2013103. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211836","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1735_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/acr.23826","volume":"72","author":"C Rempenault","year":"2020","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C (2020) Clinical and structural efficacy of hydroxychloroquine in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken) 72(1):36\u201340. https:\/\/doi.org\/10.1002\/acr.23826","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"1735_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cmet.2006.10.002","volume":"4","author":"JG Schneider","year":"2006","unstructured":"Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, Bernal-Mizrachi C, Muslin AJ, Kastan MB, Semenkovich CF (2006) ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4(5):377\u2013389. https:\/\/doi.org\/10.1016\/j.cmet.2006.10.002","journal-title":"Cell Metab"},{"issue":"3","key":"1735_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155\u2013166. https:\/\/doi.org\/10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1735_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002867","volume":"5","author":"TS Sharma","year":"2016","unstructured":"Sharma TS, Wasko MC, Tang X, Vedamurthy D, Yan X, Cote J, Bili A (2016) Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients. J Am Heart Assoc 5(1):e002867. https:\/\/doi.org\/10.1161\/JAHA.115.002867","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1735_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ame2.12065","volume":"2","author":"N Shi","year":"2019","unstructured":"Shi N, Zhang S, Silverman G, Li M, Cai J, Niu H (2019) Protective effect of hydroxychloroquine on rheumatoid arthritis-associated atherosclerosis. Anim Model Exp Med 2(2):98\u2013106. https:\/\/doi.org\/10.1002\/ame2.12065","journal-title":"Anim Model Exp Med"},{"issue":"1","key":"1735_CR38","first-page":"195","volume":"26","author":"K Shojania","year":"1999","unstructured":"Shojania K, Koehler BE, Elliott T (1999) Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis. J Rheumatol 26(1):195\u2013196","journal-title":"J Rheumatol"},{"issue":"9","key":"1735_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139226","volume":"10","author":"AM Shukla","year":"2015","unstructured":"Shukla AM, Bose C, Karaduta OK, Apostolov EO, Kaushal GP, Fahmi T, Segal MS, Shah SV (2015) Impact of hydroxychloroquine on atherosclerosis and vascular stiffness in the presence of chronic kidney disease. PLoS ONE 10(9):e0139226. https:\/\/doi.org\/10.1371\/journal.pone.0139226","journal-title":"PLoS ONE"},{"issue":"40","key":"1735_CR40","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.2174\/1381612827666210625162612","volume":"27","author":"LE Simental-Mend\u00eda","year":"2021","unstructured":"Simental-Mend\u00eda LE, Simental-Mend\u00eda M, S\u00e1nchez-Garc\u00eda A, Linden-Torres E (2021) Effect of hydroxychloroquine on lipid levels: a systematic review and metaanalysis. Curr Pharm des 27(40):4133\u20134139. https:\/\/doi.org\/10.2174\/1381612827666210625162612","journal-title":"Curr Pharm des"},{"key":"1735_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.athplu.2024.02.002","volume":"55","author":"P Simonen","year":"2024","unstructured":"Simonen P, Ulander L, Eklund KK, Niemi M, Backman JT, Gylling H, Sinisalo J, OXI Pilot Trial (2024) The effect of hydroxychloroquine on cholesterol synthesis depends on the profile of cholesterol metabolism. A controlled clinical study. Atheroscler plus 55:93\u201397. https:\/\/doi.org\/10.1016\/j.athplu.2024.02.002","journal-title":"Atheroscler plus"},{"issue":"8","key":"1735_CR42","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/s0891-5849(02)01015-8","volume":"33","author":"KY Stokes","year":"2002","unstructured":"Stokes KY, Cooper D, Tailor A, Granger DN (2002) Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 33(8):1026\u20131036. https:\/\/doi.org\/10.1016\/s0891-5849(02)01015-8","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1735_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148559","volume":"132","author":"AR Tall","year":"2022","unstructured":"Tall AR, Thomas DG, Gonzalez-Cabodevilla AG, Goldberg IJ (2022) Addressing dyslipidemic risk beyond LDL-cholesterol. J Clin Invest 132(1):e148559. https:\/\/doi.org\/10.1172\/JCI148559","journal-title":"J Clin Invest"},{"issue":"7","key":"1735_CR44","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/annrheumdis-2022-222338","volume":"81","author":"L van Ouwerkerk","year":"2022","unstructured":"van Ouwerkerk L, Palmowski A, Nevins IS, Buttgereit F, Verschueren P, Smolen JS, Landew\u00e9 RB, Bijlsma JJ, Kerschbaumer A, Westhovens R, Huizinga TW, Allaart CF, Bergstra SA (2022) Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Ann Rheum Dis 81(7):937\u2013943. https:\/\/doi.org\/10.1136\/annrheumdis-2022-222338","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1735_CR45","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00296-020-04616-2","volume":"40","author":"AI Venetsanopoulou","year":"2020","unstructured":"Venetsanopoulou AI, Pelechas E, Voulgari PV, Drosos AA (2020) The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatol Int 40(8):1181\u20131191. https:\/\/doi.org\/10.1007\/s00296-020-04616-2","journal-title":"Rheumatol Int"},{"issue":"1","key":"1735_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12902-024-01827-7","volume":"25","author":"R Wang","year":"2025","unstructured":"Wang R, Qi S, Wang Q, Lang J, Pang C, Wang K (2025) Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome. BMC Endocr Disord 25(1):2. https:\/\/doi.org\/10.1186\/s12902-024-01827-7","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"1735_CR47","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1007\/s00125-015-3689-2","volume":"58","author":"MC Wasko","year":"2015","unstructured":"Wasko MC, McClure CK, Kelsey SF, Huber K, Orchard T, Toledo FG (2015) Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial. Diabetologia 58(10):2336\u20132343. https:\/\/doi.org\/10.1007\/s00125-015-3689-2","journal-title":"Diabetologia"},{"key":"1735_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.597985","volume":"11","author":"NK Younis","year":"2020","unstructured":"Younis NK, Zareef RO, Al Hassan SN, Bitar F, Eid AH, Arabi M (2020) Hydroxychloroquine in COVID-19 patients: pros and cons. Front Pharmacol 11:597985. https:\/\/doi.org\/10.3389\/fphar.2020.597985","journal-title":"Front Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01735-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01735-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01735-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:06:33Z","timestamp":1750226793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01735-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1735"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01735-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing financial interests or personal relationships.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All subjects signed an informed consent form, in accordance with the ethical principles of the Declaration of Helsinki. The research protocol was approved by the Ethics Committee of Anhui Medical University (20170061).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}